AXSM

Axsome Therapeutics Inc

69.45
0.00 (0.0%)
Stock Name Stock Symbol Market Stock Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 69.45 18:02:34
Open Price Low Price High Price Close Price Previous Close
69.45
more quote information »

Recent News

Date Time Source Heading
30/5/202321:00GLOBEAxsome Therapeutics to Present Data and Post-Hoc Analyses on..
09/5/202320:02EDGARQuarterly Report (10-q)
09/5/202320:02EDGARSecurities Registration: Employee Benefit Plan (s-8)
08/5/202321:06EDGARCurrent Report Filing (8-k)
08/5/202321:00GLOBEAxsome Therapeutics Reports First Quarter 2023 Financial..
03/5/202321:00GLOBEAxsome Therapeutics to Present at the Bank of America..
01/5/202321:00GLOBEAxsome Therapeutics Joins Mental Health America and the..
22/4/202307:25EDGARAnnual Report to Security Holders (ars)
22/4/202307:24EDGARProxy Statement (definitive) (def 14a)
21/4/202321:00GLOBEAxsome Therapeutics to Present Five Abstracts Including New..
14/4/202321:00GLOBEAxsome Therapeutics to Present at the 22nd Annual Needham..
13/4/202321:00GLOBEAxsome Therapeutics to Report First Quarter 2023 Financial..
15/3/202300:30PRNUSSHAREHOLDER ALERT: Axsome Therapeutics, Inc. (AXSM) Officers..
13/3/202321:04EDGARCurrent Report Filing (8-k)
11/3/202307:44EDGARCurrent Report Filing (8-k)
07/3/202310:17EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202310:16EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202310:15EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202310:15EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202310:14EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202310:13EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202310:13EDGARStatement of Changes in Beneficial Ownership (4)
01/3/202323:00GLOBEAxsome Therapeutics to Present at Cowen’s 43rd Annual Health..
27/2/202323:06EDGARCurrent Report Filing (8-k)
27/2/202323:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
22/2/202323:00GLOBEAxsome Therapeutics Enters into License Agreement with..
15/2/202309:30EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202308:15EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202307:46EDGARAmended Statement of Ownership (sc 13g/a)
07/2/202323:00GLOBEAxsome Therapeutics to Present at the SVB Securities Global..
02/2/202308:56EDGARAmended Statement of Ownership (sc 13g/a)
31/1/202323:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
10/12/202203:05TRMNMizuho Securities Sticks to Their Buy Rating for Axsome..
07/12/202223:00GLOBEAxsome Therapeutics Presents New Data from the EVOLVE..
03/12/202209:28EDGARAutomatic Shelf Registration Statement of Securities of..
30/11/202216:00TRMNWall Street Analysts Are Bullish on Top Healthcare Picks
29/11/202223:30TRMNAnalysts Offer Insights on Healthcare Companies: Arrowhead..
29/11/202201:15TRMNAxsome Therapeutics Rises on Promising Alzheimer’s Results
28/11/202222:35GLOBEAxsome Therapeutics Announces AXS-05 Achieves Primary..
23/11/202223:00GLOBEAxsome Therapeutics to Present at the 5th Annual Evercore..
23/11/202214:05TRMNMizuho Securities Remains a Buy on Axsome Therapeutics..
15/11/202209:53EDGARCurrent Report Filing (8-k)
10/11/202215:26TRMNSVB Securities Reaffirms Their Buy Rating on Axsome..
09/11/202223:00GLOBEAxsome Therapeutics to Present at the Guggenheim 4th Annual..
09/11/202203:35TRMNMorgan Stanley Reaffirms Their Hold Rating on Axsome..
07/11/202223:00GLOBEAxsome Therapeutics Reports Third Quarter 2022 Financial..
04/11/202216:05TRMNSVB Securities Sticks to Its Buy Rating for Axsome..
27/10/202222:00GLOBEAxsome Therapeutics to Ring the NASDAQ Stock Market Opening..
25/10/202207:02EDGARStatement of Ownership (sc 13g)
25/10/202200:35TRMNH.C. Wainwright Sticks to Their Buy Rating for Axsome..
Your Recent History
NASDAQ
AXSM
Axsome The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230531 09:28:36